RTOG 0424: PHASE II STUDY OF A TEMOZOLOMIDE (TMZ)-BASED CHEMO-RADIOTHERAPY (RT) REGIMEN FOR HIGH RISK LOW-GRADE GLIOMAS (LGGS) PRELIMINARY RESULTS INCLUDING QUALITY OF LIFE (QOL) AND NEUROLOGICAL FUNCTION (NCF) Conference

Fisher, Barbara, Chen, Hu, Macdonald, David et al. (2013). RTOG 0424: PHASE II STUDY OF A TEMOZOLOMIDE (TMZ)-BASED CHEMO-RADIOTHERAPY (RT) REGIMEN FOR HIGH RISK LOW-GRADE GLIOMAS (LGGS) PRELIMINARY RESULTS INCLUDING QUALITY OF LIFE (QOL) AND NEUROLOGICAL FUNCTION (NCF) . NEURO-ONCOLOGY, 15 77-77.

International Collaboration

cited authors

  • Fisher, Barbara; Chen, Hu; Macdonald, David; Lesser, Glenn; Coons, Stephen; Brachman, Daniel; Ryu, Samuel; Werner-Wasik, Maria; Bahary, Jean-Paul; Chakravarti, Arnab; Mehta, Minesh

sustainable development goals

authors

date/time interval

  • November 21, 2013 -

publication date

  • November 1, 2013

webpage

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • San Francisco, CA

Conference

  • 4th Quadrennial Meeting of the World-Federation-of-Neuro-Oncology (WFNO) held in conjunction with the 18th Annual Meeting of the Society-for-Neuro-Oncology (SNO)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 77

end page

  • 77

volume

  • 15